4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-24-003283
Options or other derivatives
- EVP, Chief Commercial Officer acquired 8,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Santos David A · EVP, Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-25 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +8,000 | 8,000 | D |
Loading xslF345X05/form4.xml…